期刊文献+

前列腺肿瘤生物学标记的新进展

下载PDF
导出
摘要 在美国,前列腺肿瘤是男性最常见的恶性肿瘤,也是男性第五大致死疾病[1]。据估计,2013年有超过230000的男性被诊断为前列腺肿瘤,其中约29000人死于本病(12%)。大约60%的前列腺肿瘤发生在66岁以上的老年男性,相比白人美国男性,亚裔美国男性前列腺肿瘤的发病率低50%[2]。男性前列腺肿瘤患者生存率在男性肿瘤患者生存率中是最高的,约占所有男性肿瘤患者生存率的40%[3]。在中国特别是偏远地区。
出处 《泌尿外科杂志(电子版)》 2014年第1期33-36,共4页 Journal of Urology for Clinicians(Electronic Version)
  • 相关文献

参考文献11

  • 1杨杰,张嘉宜,宋宁宏.miRNAs在前列腺癌激素非依赖性进展中的研究[J].中华男科学杂志,2013,19(9):831-834. 被引量:3
  • 2Jonathan E. McDunn,Zhen Li,Klaus‐Peter Adam,Bruce P. Neri,Robert L. Wolfert,Michael V. Milburn,Yair Lotan,Thomas M. Wheeler.Metabolomic signatures of aggressive prostate cancer[J].Prostate.2013(14)
  • 3Massimo Lazzeri,Alberto Abrate,Giovanni Lughezzani,Giulio Maria Gadda,Massimo Freschi,Francesco Mistretta,Giuliana Lista,Nicola Fossati,Alessandro Larcher,Ella Kinzikeeva,Nicolòmaria Buffi,Vincenzo Dell’Acqua,Vittorio Bini,Francesco Montorsi,Giorgio Guazzoni.Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination[J].Urology.2013
  • 4Massimo Lazzeri,Alexander Haese,Alberto Abrate,Alexandre Taille,Joan Palou Redorta,Thomas McNicholas,Giovanni Lughezzani,Giuliana Lista,Alessandro Larcher,Vittorio Bini,Andrea Cestari,Nicolòmaria Buffi,Markus Graefen,Olivier Bosset,Philippe Le Corvoisier,Alberto Breda,Pablo Torre,Linda Fowler,Jacques Roux,Giorgio Guazzoni.Clinical performance of serum prostate‐specific antigen isoform [‐2] proPSA ( p2PSA ) and its derivatives, % p2PSA and the prostate health index ( PHI ), in men with a family history of prostate cancer: results from a multicentre E uropean study, the PROMEtheuS project[J].BJU Int.2013(3)
  • 5Simpa S. Salami,Folke Schmidt,Bharathi Laxman,Meredith M. Regan,David S. Rickman,Douglas Scherr,Gerardina Bueti,Javed Siddiqui,Scott A. Tomlins,John T. Wei,Arul M. Chinnaiyan,Mark A. Rubin,Martin G. Sanda.Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer[J].Urologic Oncology: Seminars and Original Investigations.2013(5)
  • 6Sigrid Carlsson,Alexandra Maschino,Fritz Schr?der,Chris Bangma,Ewout W. Steyerberg,Theo van der Kwast,Geert van Leenders,Andrew Vickers,Hans Lilja,Monique J. Roobol.Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam[J].European Urology.2013
  • 7Tapan Bhavsar,Peter McCue,Ruth Birbe.Molecular Diagnosis of Prostate Cancer: Are We Up to Age?[J].Seminars in Oncology.2013(3)
  • 8Damali N. Martin,Adrienne M. Starks,Stefan Ambs.Biological determinants of health disparities in prostate cancer[J].Current Opinion in Oncology.2013(3)
  • 9M. L. Verschoor,R. Ungard,A. Harbottle,J. P. Jakupciak,R. L. Parr,G. Singh,George Perry.Mitochondria and Cancer: Past, Present, and Future[J].BioMed Research International.2013
  • 10Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J].CA: A Cancer Journal for Clinicians.2013(1)

二级参考文献2

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部